Cancer Metabolomics

Cancer is an overwhelming sickness that changes the digestion system of a cell and the encompassing milieu.  in pharmaceutical examination Metabolomics is a generally quick and precise procedure that can be connected with either turning into an inexorably mainstream instrument in the life sciences or in a worldwide way to uncover new learning about organic frameworks.  The Division of Cancer Biology (DCB) bolsters and encourages fundamental examination in every aspect of tumor science at scholastic establishments and exploration establishments over the United States and abroad. Cancer biomarkers in the clinic, to find pathways included in disease that could be utilized for new targets and to screen metabolic biomarkers amid remedial mediation.

 

  • Gene therapy
  • Cancer immunotherapy
  • Metabolic profiling in cancer
  • Active immunotherapies

Related Conference of Cancer Metabolomics

May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

A Coruna, Spain

Cancer Metabolomics Conference Speakers